An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure

Journal of Glaucoma

Volumn 17, Issue 8, 2008, Pages 674-679

  Hatanaka, Marcelo ^a   Grigera, Daniel E ^b   Barbosa, Wilma L ^c   Jordao, Marcelo ^d   Susanna, Remo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DEL SALVADOR   (Argentina)

^c UNIVERSITY OF TAUBATÉ   (Brazil)

^d HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Brimonidine; Clinical management; Diurnal tension curve; Dorzolamide; Fixed combinations; Ocular hypertension; Open angle glaucoma; Timolol; Water drinking test

Indexed keywords

BRIMONIDINE PLUS TIMOLOL; DORZOLAMIDE PLUS TIMOLOL; WATER; ANTIHYPERTENSIVE AGENT; BRIMONIDINE; DORZOLAMIDE; EYE DROPS; QUINOXALINE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE; TIMOLOL;

ADULT; AGED; ARGENTINA; ARTICLE; BRAZIL; BURNING SENSATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY EYE; DYSPNEA; EVENING DOSAGE; FEMALE; FOREIGN BODY SENSATION; HUMAN; HYPEREMIA; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; WATER LOADING; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DRUG COMBINATIONS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; QUINOXALINES; SULFONAMIDES; THIOPHENES; TIMOLOL; TONOMETRY, OCULAR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60749130612     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318168f008     Document Type: Article

References (21)

1. World Health Organization. Blindness: Vision 2020 - The Global Initiative for the Elimination of Avoidable Blindness. Geneva: WHO; 2000: Fact Sheet 213:1.
2. Strohmaier K, Snyder E, DuBiner H, et al. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group. Ophthalmology. 1998;105:1936-1944.
3. Choudhri S, Wand M, Shields MB. A comparison of dorzolamidetimolol combination versus the concomitant drugs. Am J Ophthalmol. 2000;130:832-833.
4. Walters TR. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies (review). Surv Ophthalmol. 1996;41:S19-S26.
5. Toris CB, Gleason ML, Camras CB, et al. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113:1514-1517.
6. Craven ER, Walters TR, Williams R, et al, Combigan Study Group. Brimonidine and timolol fixed-combination therapy versus mono- therapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension. J Ocul Pharmacol Ther. 2005;21:337-348.
7. Chan K, Testa M, McCluskey P. Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%. J Ocul Pharmacol Ther. 2007;23: 372-376.
8. Arcieri ES, ARcieri RS, Pereira AC, et al. Comparing the fixed combination brimonidine-timolo versus fixed combination dorzola-mide-timolol in patients with elevated intraocular pressure. Curr Med Res Opin. 2007;23:683-689.
9. Miller D. The relationship between diurnal tension variation and the water-drinking test. Am J Ophthalmol. 1964;58:243-247.
10. Frankelson EN. The role of the water test in evaluation of glaucoma control. Can J Ophthalmol. 1974;9:408-410.
11. Helal J. Contribuição ao estudo da pressão intra-ocular: picos de pressao intra-ocular na curva diaria de pressão e na prova de sobrecarga hidrica. Rev Bras Oftal. 1988;47:75-80.
12. Medeiros FA, Pinheiro A, Susanna R Jr, et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther. 2002;18:489-498.
13. Susanna R Jr, Medeiros FA, Vessani RM, et al. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone. J Ocul Pharmacol Ther. 2004;20:401-410.
14. Susanna R Jr, Sheu W. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Clin Ther. 2004; 26:755-768.
15. Vetrugno M, Sisto D, Trabucco T, et al. Water drinking test in patients with primary open-angle glaucoma while treated with different topical medications. J Ocul Pharmacol Ther. 2005;21: 250-257.
16. Susanna R Jr, Hatanaka M, Vessani RM, et al. Correlation of asymmetric glaucomatous visual field damage and water-drinking test response. Invest Ophthalmol Vis Sci. 2006;47:641-644.
17. Susanna R Jr, Vessani RM, Sakata L, et al. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol. 2005;89:1298-1301.
18. Yoshikawa K, Inohue T, Inohue Y. Normal tension glaucoma: the value of predictive tests. Acta Ophthalmol. 1993;71:463-470.
19. Armaly MF, Krueger DE, Maunder L, et al. Biostatistical analysis of the Collaborative Glaucoma Study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 1980;98:2163-2171.
20. Crichton ACS. Timolol/brimonidine combination therapy in glaucoma management. Clin Surg J Ophthalmol. 2005;23:10.
21. Ahmed IIK. Combigan early experience data trial (CEED II): an in-depth look at the latest findings. qqqqClin Surg J Ophthalmol. 2007;25:2.